Sign in

    Bradley Sorensen

    Senior Equity Research Analyst at Analyst

    Brad Sorensen is a Senior Equity Research Analyst at Zacks Small Cap Research, specializing in small-cap equities across a variety of market sectors with particular expertise developed from his prior role as Managing Director of Market and Sector Analysis at Charles Schwab. He has conducted in-depth research on numerous public companies, including those traded on the OTCQX and other emerging growth firms, and has provided widely read market commentary and weekly research updates for thousands of investors. With over 20 years of investment industry experience, Sorensen joined Zacks in 2021 after a distinguished tenure at Schwab, where he also served as Director of Sector Analysis. He holds the CFA charter and has completed both an MBA and an MS in Finance from the University of Colorado, consistently contributing financial insights featured in national media outlets.

    Bradley Sorensen's questions to BIOSTEM TECHNOLOGIES (BSEM) leadership

    Bradley Sorensen's questions to BIOSTEM TECHNOLOGIES (BSEM) leadership • Q2 2024

    Question

    Bradley Sorensen inquired about BioStem's supply chain and manufacturing capacity, questioning if there were any constraints given the rapidly increasing demand.

    Answer

    Executive Jason Matuszewski confirmed that BioStem is proactively managing its supply chain by working with recovery partners to forecast demand. He also detailed a manufacturing expansion, with plans to add eight new clean rooms to its Pompano Beach facility, bringing the total to 17, and noted that the company is considering a larger, separate site in the near future to meet anticipated demand.

    Ask Fintool Equity Research AI